DeepkinetiX

Website

DeepkinetiX Inc.

1 Investors
Pharmaceutical Technology
CAMBRIDGE, MA

DeepkinetiX Inc. is a pioneering company dedicated to revolutionizing the drug development landscape through the innovative application of artificial intelligence and computational modeling techniques. By employing advanced technologies, they strive to optimize pharmacokinetic and pharmacodynamic processes, fostering speed and precision in drug analysis.

Products & Team

KinetixFlow™

Software PlatformSeed

KinetixFlow™ is an advanced AI-powered software platform specifically designed for pharmacokinetic and pharmacodynamic analysis. It integrates complex algorithms to analyze extensive data sets, predicting how drugs will behave in the human body and significantly optimizing dosing strategies.

Value Proposition

KinetixFlow™ effectively addresses the limitations of traditional drug development methods by reducing the need for animal testing while providing faster, more accurate insights into drug behavior, ultimately leading to reduced development timelines and improved success rates.

Pain Points

Customers face challenges such as high costs and inefficiencies in traditional drug development processes, reliance on animal testing, and the need for more accurate predictive modeling to enhance drug success rates.

AI-driven predictive analyticsReal-time pharmacokinetic/pharmacodynamic modelingEnhanced accuracy with patient-derived cellular dataStreamlined workflows for drug discovery and trial design
Industry
Other Technology
Primary business sector
Founded
2025
Year established
Location
CAMBRIDGE, MA
Primary headquarters

Funding History

Total Raised:
$1.0M
E

Option to Acquire Offering

March 2025
$2.5M
Target
Progress
40%
Raised
$1.0M
Target
$2.5M
#000206028825000001